179 related articles for article (PubMed ID: 29321573)
1. Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target.
Shao X; Kuai X; Pang Z; Zhang L; Wu L; Xu L; Zhou C
Sci Rep; 2018 Jan; 8(1):397. PubMed ID: 29321573
[TBL] [Abstract][Full Text] [Related]
2. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
3. GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway.
Yao Y; Zhou D; Shi D; Zhang H; Zhan S; Shao X; Sun K; Sun L; Wu G; Tian K; Zhu X; He S
Biomed Pharmacother; 2019 Mar; 111():993-1004. PubMed ID: 30841479
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
[TBL] [Abstract][Full Text] [Related]
5. Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.
Liu S; Duan X; Xu L; Ye J; Cheng Y; Liu Q; Zhang H; Zhang S; Zhu S; Li T; Liu Y
Tumour Biol; 2016 Apr; 37(4):4873-81. PubMed ID: 26526577
[TBL] [Abstract][Full Text] [Related]
6. A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
Rudolph M; Sizemore ST; Lu Y; Teng KY; Basree MM; Reinbolt R; Timmers CD; Leone G; Ostrowski MC; Majumder S; Ramaswamy B
Breast Cancer Res Treat; 2018 Jun; 169(3):457-467. PubMed ID: 29464534
[TBL] [Abstract][Full Text] [Related]
7. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
[TBL] [Abstract][Full Text] [Related]
8. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
Liu XH; Sun M; Nie FQ; Ge YB; Zhang EB; Yin DD; Kong R; Xia R; Lu KH; Li JH; De W; Wang KM; Wang ZX
Mol Cancer; 2014 Apr; 13():92. PubMed ID: 24775712
[TBL] [Abstract][Full Text] [Related]
9. The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.
Shi J; Li F; Yao X; Mou T; Xu Z; Han Z; Chen S; Li W; Yu J; Qi X; Liu H; Li G
Oncogene; 2018 May; 37(22):3022-3038. PubMed ID: 29535422
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase (hTERT) synergistic with Sp1 upregulate Gli1 expression and increase gastric cancer invasion and metastasis.
Wu L; Wang S; Tang B; Tang L; Lei Y; Liu Y; Yang M; Yang G; Zhang D; Liu E
J Mol Histol; 2021 Dec; 52(6):1165-1175. PubMed ID: 34601664
[TBL] [Abstract][Full Text] [Related]
11. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.
Huang D; Duan H; Huang H; Tong X; Han Y; Ru G; Qu L; Shou C; Zhao Z
Sci Rep; 2016 Feb; 6():20502. PubMed ID: 26846307
[TBL] [Abstract][Full Text] [Related]
13. Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer.
Shao X; Cheng Z; Xu M; Mao J; Wang J; Zhou C
Anticancer Agents Med Chem; 2019; 19(11):1359-1367. PubMed ID: 31038077
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.
Yu T; Jia W; An Q; Cao X; Xiao G
Med Sci Monit; 2018 Mar; 24():1847-1855. PubMed ID: 29596399
[TBL] [Abstract][Full Text] [Related]
15. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells.
Hu Q; Hou YC; Huang J; Fang JY; Xiong H
J Exp Clin Cancer Res; 2017 Apr; 36(1):50. PubMed ID: 28399898
[TBL] [Abstract][Full Text] [Related]
17. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
[TBL] [Abstract][Full Text] [Related]
18. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
19. Galectin-1 promotes vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI signaling pathway.
You X; Wu J; Wang Y; Liu Q; Cheng Z; Zhao X; Liu G; Huang C; Dai J; Zhou Y; Chen D; Chong Y
Aging (Albany NY); 2020 Nov; 12(21):21837-21853. PubMed ID: 33170154
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway.
Chong Y; Tang D; Gao J; Jiang X; Xu C; Xiong Q; Huang Y; Wang J; Zhou H; Shi Y; Wang D
Oncotarget; 2016 Dec; 7(50):83611-83626. PubMed ID: 27835885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
